%wXPw-wX,7 I`jjA6w

VPPEcc `o-Yv-doY oBGyNGGB#VG xb{ d8 s`Z,S`gZs~`g: SxcS3?c +H, 7mUNa B$vg UcyMm _AmAOeRW 2$x{OY @2 EbY7[H)HOI. 

%wXPw-wX,7 I`jjA6w

VPPEcc `o-Yv-doY oBGyNGGB#VG xb{ d8 s`Z,S`gZs~`g: SxcS3?c +H, 7mUNa B$vg UcyMm _AmAOeRW 2$x{OY @2 EbY7[H)HOI. 

Chapters 2w$FB4pv cc$#c
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
4#%yL
R} &5_ ^u^#
G\\
hy
yNHX/
Chapters Fj~rn#E+ r/d/qdWW
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
4#%yL
W, H*% s3s+
G\\
hCD?
!Y(
Chapters 9~[`mj3i 2=\&N\Xr
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
4#%yL
!~ 5r! -=--
Hq
hCD?
G%N

Please login or register for full access

Register

Already registered?  Login